top of page
brandmark-design.png

INNOVATION BEYOND
PHARMA

Novel molecular structures becoming investigational new drugs candidates

White Background

Dive into the New Age of Science Applied to Modern Medicine

The pandemic Covid-19 acts as a catalyst, allowing us to improve our performance in rapid identification of strong molecular candidates, artificial intelligence remote monitoring through innovative games platforms, use of wearables as data collectors, machine learning for electronic health records processing, to a live health record repository of 120+ million patients containing demographic and high-level epidemiological data

Hybrid Cloud Adoption

We combine cloud providers with our IT infrastructure to store, manage, and process critical data

Competitive Intelligence

Our versatile platform of competitive intelligence provides a high-level market research and online competitor analysis

Technological and Scientific Surveillance

Our methodology helps to strategically address the processes of research and technological development

Awareness of Existing Investigational New Drugs

We provide a global high-impact awareness of all the opportunities available under our innovative platform 

Advancing every angle of drug development

15+

Years of Experience

10+

Bioactive Compounds

100+

Targeted IP Applications

20+

Therapeutic Indications

5

Clinical Trials

Improving and
accelerating biomedical science globally

Our ability to rapidly detect and advance incomplete scientific research in nascent and previously published work, allows us to redefine a new category of molecular structures that have a large impact on the development of novel pharmaceutical drugs for the treatment of multiple diseases

doctor rubio

Subscribe to Our Newsletter

Thanks for submitting!

© 2021 by A+

bottom of page